Yuqiang Wang

Company: Magpie Pharmaceuticals

Job title: Founder and CEO

Seminars:

Novel Multi-functional Small Molecule TBN Proves Promising in ALS Phase II Trial 2:10 pm

Optimizing recruitment strategy to achieve a significantly large phase 2 cohort of Chinese patients Outlining the observed effects on grip strength and other key markers of ALS progression Advancing TBN into a phase 3 study in ChinaRead more

day: Day Two Track B PM